Recent Headlines
Credo Biomedical to Present at Animal Health Innovation Summit
Credo Biomedical is one of the 12 finalists that have been selected to showcase during the Animal Health Innovation Summit in Hong Kong. - October 21, 2018 - Credo Biomedical Pte. Ltd.
Epitope Diagnostics, Inc. Certifies Its Total 25-OH Vitamin D EIA Kit Through the CDC’s Vitamin D Standardization-Certification Program (VDSCP)
Epitope Diagnostics, Inc. (EDI), is pleased to announce it has received certification for the Vitamin D Standardization Program (VDSP) for vitamin D measurement in the EDI™ Total 25-OH Vitamin D EIA Kit. CDC’s Vitamin D Standardization-Certification Program (VDSCP) evaluates the... - October 21, 2018 - Epitope Diagnostics, Inc.
Energy for Health, ASAlaser's Scientific Review: 10 Years Marked by Research, Dissemination and Promotion of Scientific Knowledge
A new finish line accomplished for ASAlaser, whose scientific magazine celebrates its first ten years in 2018. The magazine represents just one of the company’s initiatives for highlighting research, the focal point of its growth and the basis of its ethics. - October 19, 2018 - ASA srl
ALPCO Announces Inaugural Young Investigators Award Recipient
ALPCO announces the first recipient of its new young investigators award, the Diabetes Research Travel Grant. - October 17, 2018 - ALPCO
Can't Smell Anything? This Clinical Trial May Give You Hope.
We often take for granted the ability to smell, but people with a diminished sense of smell or who have lost this sense completely know that this ability is linked to our overall quality of life. It is a major contributor to our ability to taste food, and people who lose their sense of smell often lose their appetite. This clinical trial may give them hope. - October 15, 2018 - Foundation for Regenerative Medicine
ALPCO’s Quality Management System Receives ISO 13485:2016 Certification
ALPCO announces that its quality management system recently received the distinguished ISO 13485:2016 certification from Intertek to ensure the quality, safety and efficacy of its products in the clinical diagnostics field. - October 09, 2018 - ALPCO
ProPath Selected as Medical Director for Baylor Scott & White Medical Center – Sunnyvale
ProPath is pleased to announce that they have been selected as the pathology service provider for Baylor Scott & White Medical Center – Sunnyvale. In addition, ProPath’s Dr. Isabel Hill has been named Medical Director of Pathology Services. “ProPath is excited to provide the... - October 04, 2018 - ProPath
ASAlaser Therapies and the Italian Fencing Federation: 10 Years of Medals
The Olympics, the World Championships and international competitions distinguished by victories have marked the ten years of collaboration between the Italian company ASAlaser from Vicenza, manufacturer of lasers for rehabilitation and physiotherapy, and the Azzurri Italian fencing team. These were also underlined by the recent successes at Wuxi 2018. - September 27, 2018 - ASA srl
Epitope Diagnostics, Inc. Joins MetroConnect to Expand International Growth
Epitope Diagnostics, Inc. is pleased to announce it has been selected to take part in MetroConnect 2018, an export assistance program run by the World Trade Center San Diego (WTC) and designed to help San Diego companies accelerate their global growth. This program will allow Epitope Diagnostics... - September 23, 2018 - Epitope Diagnostics, Inc.
Julien Dagenais, M.D. and Christopher Dru, M.D., Join The Urology Center of Colorado
The addition of the two new urologists/robotic surgeons will bring The Urology Center of Colorado (TUCC) to a total of 18 physicians and 4 advanced practice providers to remain the largest urology group in Colorado. All TUCC physicians are sub-specialists committed to providing excellence at every encounter. - September 21, 2018 - The Urology Center of Colorado
Fertility Preservation Network Welcomes Dallas, Texas Facility
Program greatly extends access to fertility preservation services. - September 20, 2018 - ReproTech, LLC
VirtuOx and Brightree Launch Diagnostic Testing Integration
VirtuOx, one of the world’s largest home diagnostic testing providers, and Brightree®, the leading provider of cloud-based healthcare software and solutions for the post-acute market, have announced a completed integration that enables streamlined workflows for home medical equipment... - September 17, 2018 - VirtuOx
Recovery Unplugged to be Featured in USA Today for “Three Moms” Campaign
Recovery Unplugged Treatment Centers is being featured in USA Today's Addiction and Mental Health Awareness issue on Thursday, September 13th. The "Three Stories" multimedia campaign created by Recovery Unplugged highlights the stories of three mothers and their children who have made it to the other side of addiction - together. - September 08, 2018 - Recovery Unplugged
Recovery Unplugged Kicks Off National Recovery Month Campaign
Recovery Unplugged Treatment Centers kicked-off a multimedia marketing campaign in observance of National Recovery Month. The campaign aims to promote awareness, education, and empowerment throughout the recovery community and their loved ones. Content is being created that celebrate those in recovery, provide information to help people stay clean, and educate loved ones about treatment and the recovery process. - September 08, 2018 - Recovery Unplugged
Experimentica Ltd. Presents at the ISER in Belfast, Northern Ireland - XXIII Biennial Meeting of the International Society for Eye Research September 9-13, 2018 | Belfast
The XXXIII Biennial Meeting of the International Society of Eye Research takes place this year from September 9-13th in Belfast, Northern Ireland, UK. Dr Jenni J. Hakkarainen – Acting COO of Experimentica Ltd. will present an oral presentation on a metalloporphyrin superoxide dismutase mimetic and the dry-eye disease. Dr Simon Kaja – CSO of Experimentica Ltd. will chair a session and present on cellular mechanisms of reactive astrocytosis and opportunities for glioprotection. - September 08, 2018 - Experimentica Ltd
Trial Runners Strengthens Its Leadership Team
Trial Runners is pleased to announce additions to their executive team as well as their leadership team as a result of a fast-paced growth year. - August 17, 2018 - Trial Runners
ClinTex CTi Leverages Distributed Ledger Technology to Lower the Cost of Medicine
CTi (Clinical Trials Intelligence) aims to bring down the cost of medicine, as well as increase the speed of access to new medicine, by reducing development costs for the global pharmaceutical industry. - August 08, 2018 - ClinTex Ltd
ALPCO to Exhibit at the AACC’s 70th Annual Scientific Meeting and Clinical Lab Expo
ALPCO will promote the expansion of its STELLUX® Chemiluminescence ELISA platform, as well as its current therapeutic drug monitoring portfolio, gastroenterology testing panel, and assay qualification program at AACC’s 70th Annual Clinical Lab Expo. - July 25, 2018 - ALPCO
ALPCO and InSphero Partner to Offer a Complete Solution to Assess Beta-cell Function in Islet Microtissue Culture Models
ALPCO and InSphero announce partnership to provide customers with a complete solution to assess beta-cell function in islet microtissue culture models. - July 24, 2018 - ALPCO
The Summer Season is Safe for Sufferers of "Swimmer’s Shoulder" Thanks to ASAlaser Therapies
The ASAlaser therapeutic solutions are an effective answer in order to successfully treat one of the most common issues for freestyle and backstroke lovers. Hilterapia® and MLS® provide a fast reduction in pain and a speedy recovery of the joint’s action. - July 22, 2018 - ASA srl
Cayman Partners with LIPID MAPS® to Support Continued Development of Key Lipidomic Research Resources
Cayman has increased its financial support of the LIPID MAPS® Lipidomics Gateway. The newly launched LIPID MAPS® website (June 2018) provides easy access to free tools and resources, including a searchable lipid structure database (with over 43,000 entries), mass spectrometry spectra prediction tools, lipid structure drawing tools, experimental protocols, systems biology pathway maps, statistical analysis tools, and a curated lipid standards database. - July 21, 2018 - Cayman Chemical Company
New Assay for Immunology Research Quantifies cGAS-Produced 2’3’-cGAMP in Cells
Sensitive and direct measurement of cGAMP levels in cell lysates is now possible with Cayman’s much-anticipated 2’3’-cGAMP ELISA Kit. Developed by Cayman scientists, in conjunction with expert nucleotide scientists at Biolog Life Science Institute in Germany, this competitive... - July 20, 2018 - Cayman Chemical Company
Leaders from Pfizer, Sanofi, Eli Lilly and Applied Informatics to Speak on Artificial Intelligence at Pharma Innovation Conference
Dr. Chintan Patel to discuss the implementation of AI & machine learning in clinical development. - July 19, 2018 - Applied Informatics
Minus K Technology Announces Sixth U.S. Educational Giveaway
Celebrating its 25th year in business Minus K Technology, Inc. is giving away $20,000* worth of patented vibration isolators to colleges within the United States. - July 18, 2018 - Minus K Technology Inc.
ALPCO Releases STELLUX® Chemi Active GLP-1 (7-36) Amide ELISA to Accurately Quantify Fasted Levels
ALPCO, a leading producer of research and clinical immunoassays, recently announced the launch of its STELLUX® Chemi Active GLP-1 (7-36) amide ELISA. The chemiluminescence ELISA features increased sensitivity to accurately quantify active GLP-1 (7-36) amide levels as low as 1.5 pg/mL with a 25... - July 17, 2018 - ALPCO
Dr. Alan Michelson to Advise LightIntegra Technology
Platelet expert, Dr. Alan Michelson has begun consulting as a Scientific Advisor to LightIntegra Technology, the creators of the ThromboLUX System. - June 26, 2018 - LightIntegra Technology
Speakers Inspire Audience at Regional Conference on Necrotizing Enterocolitis
The inaugural Speaking of NEC: Unplugged event, a one-day regional conference focused on identifying practical solutions for reducing the devastating effects of Necrotizing Enterocolitis (NEC) on premature infants and their families took place on June 11, 2018 at the Courtyard by Marriott in... - June 20, 2018 - The Morgan Leary Vaughan Fund, Inc.
ALPCO to Feature New STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at ADA’s 78th Scientific Sessions
ALPCO will promote its new STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at the American Diabetes Association’s 78th Scientific Sessions June 22-26, 2018 in Orlando, FL. - June 19, 2018 - ALPCO
Perthera to Exhibit at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
Perthera, Inc., the leading Therapeutics Intelligence Company™, is attending the 2018 ASCO Annual Meeting at McCormick Place, Chicago, IL, June 1-5, 2018. Perthera science and clinical results will be represented in a Podium Presentation, 2 Poster Presentations and a Symposium Breakfast. - May 30, 2018 - Perthera, Inc.
Book on New Way of Doing Medicine Could Save Lives
Adult Stem Cell Released Molecules is a new book on therapeutic development and medicine, by California author Dr. Greg Maguire, Ph.D., that could save lives and restore health. Dr. Greg Maguire's book offers a radically new approach to the standard means of developing therapeutics through the use of the molecules that stem cells release, emphasizing that the molecules act in the organisms through their collective actions within and between all levels of the system, often not at the genome. - May 23, 2018 - BioRegenerative Sciences, Inc.
Perthera Hosts Breakfast Symposium at the 2018 ASCO Annual Meeting
Perthera, Inc., the leading Therapeutics Intelligence Company™, will be hosting a networking breakfast and educational session on Monday, June 4th from 6:30 – 7:30 a.m. for attendees of the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. The breakfast symposium will be... - May 22, 2018 - Perthera, Inc.
Mercodia Launches Unique Quality System
The immunoassay company Mercodia today announces the launch of MAQS – the Mercodia Assay Quality System. With this program, Mercodia is the first company in the field of immunoassays to set a standard for quality, ensuring customer satisfaction in all parts of its offers. Today, many... - May 17, 2018 - Mercodia AB
$3.7M Research Grant Awarded to Artificial Intelligence Project for Medical Imaging
University of Waterloo’s Kimia receives $3.7M for its AI project for digital pathology. - May 16, 2018 - Kimia Lab, University of Waterloo
Wellness Family Medicine RN, Betty Abernathy, Approved with Aetna
Wellness Family Medicine Registered Nurse, Betty Abernathy, has been approved with Aetna. "Aetna health insurance products include medical, pharmacy, dental, behavioral health, group life and disability plans." (https://www.aetna.com/about-us/aetna-facts-and-subsidiaries.html) Betty has... - May 10, 2018 - Wellness Family Medicine
Betty Abernathy, RN at Wellness Family Medicine, Now Accepts First Choice by Select Health of South Carolina
Patients who are insured by First Choice by Select Health of South Carolina can now be seen by registered nurse Betty Abernathy. - May 09, 2018 - Wellness Family Medicine
Apostle Inc Announces Acceptance Into the StartX Accelerator Program
Apostle Inc is pleased to announce it’s been accepted into the prestigious StartX accelerator program. StartX is a renowned educational non-profit that accelerates the development of Stanford's top entrepreneurs through experiential education and collective intelligence. The acceptance rate has been between 8%-10%. - May 05, 2018 - Apostle Inc
EpicentRx Announces First Ever Treatment of Cancer Patient with Personalized, Custom-Made Viral Vaccines
EpicentRx, a San Diego biotechnology company developing a next-generation immunotherapy platform of viruses that infect and kill cancer cells for the treatment of several tumor types, has developed the first ever series of oncolytic viruses tailored to tumors of individual patients. The first... - May 03, 2018 - EpicentRx, INC
Oxipit’s Chest X-Ray Search Solution Selected as One of Top Innovations by SIIM
Oxipit’s ChestGlass has been selected as one of the top projects for the 2018 Society for Imaging Informatics in Medicine (SIIM) Innovation Challenge. ChestGlass is the first-to-market chest X-ray search solution that allows to find radiologically similar images in a given database. - April 27, 2018 - Oxipit
New Purpose-Built MaxSpec™ Standards Available for Quantitative Mass Spectrometry Analysis
Cayman Chemical has launched a new line of ready-to-use, quantitative lipid standards prepared specifically for mass spectrometry applications. This new line of MaxSpec™ analytical standards complements Cayman’s high-purity, basic research tools that researchers have been using for more... - April 18, 2018 - Cayman Chemical Company
Assisted Reproductive Technology / In Vitro Fertilization (ART / IVF) Success is Lower in Young Women; Its Decline Begins Earlier Than Thought, Occurs at Increasing Rates
Previously, it was assumed that ART/IVF success in women using their fresh embryos remains stable until mid-30s before it begins to decline. But a new study of CDC data with almost half a million cycles disproves this and shows success is lower also in very young women, up to age 28, and declining thereafter. Age-driven decline begins earlier than at previously thought mid-30s and occurs at increasing rates. Infertile women older than 30 should not delay ART/IVF treatment, if it is their option. - April 13, 2018 - Stats of the ART
Cyrus Diagnostic Imaging Now Offers Enhanced Patient Comfort and Power in MRI Exams
The accommodating features of the MAGNETOM Skyra, combined with 3 Tesla (T) magnet strength – the strongest clinically available– means that Cyrus Diagnostic Imaging patients can now enjoy a larger array of imaging options with high quality images. - April 11, 2018 - Cyrus Diagnostic Imaging
Apostle Inc Announces Joint Venture with Southern University of Science and Technology in the Greater China Region
Apostle Inc is pleased to announce the launch of a joint venture with Southern University of Science and Technology (SUSTech) in Shenzhen, China. The joint venture, Apostle-SUSTech Inc, will focus on the scientific and business activities in the Greater China region. David Ge, President of Apostle... - April 04, 2018 - Apostle Inc
Betty Abernathy, FNP, MSN, Approved with TRICARE
Wellness Family Medicine in Spartanburg, South Carolina is happy to announce that as of March 25, 2018 Registered Nurse, Betty Abernathy, is now in network with TRICARE insurance. - March 31, 2018 - Wellness Family Medicine
The Outdoor Sports Season is Underway: ASAlaser's Therapies Provide Valuable Assistance in Treating Foot Issues
MLS® and Hilterapia® prove to be successful in enabling runners and bikers to resume sports activities after forced stops due to painful issues of the ankle-foot-heel. - March 24, 2018 - ASA srl
NCHQA's Choosing Wisely® in NC Program Significantly Reduces Unnecessary Medical Tests and Antibiotic Overuse
The Choosing Wisely® in North Carolina initiative – which aims to reduce health care waste by helping patients make smart and effective health care choices – has resulted in significant reductions in the unnecessary use of antibiotics, Pap tests and scans for osteoporosis. - March 23, 2018 - NCHQA
ClinSearch Announces Transition in Leadership Team Welcomes Mark M. McKenzie, M.D. as Medical Director
ClinSearch, Clinical Research Specialists announces a transition in leadership at the 25-year-old clinical research site. Dr. Mark M. McKenzie is succeeding ClinSearch founder Dr. Richard A. Krause as medical director. “I have a passion for medical care and the difference it makes in the... - March 10, 2018 - Wake Research Associates
Atlanta Center for Medical Research Selected for Award
Georgia Bio honors ACMR with a Georgia Bio Community Award. - March 03, 2018 - Atlanta Center for Medical Research
Clear Scientific Announces New Aspergillus Testing Product for Booming Cannabis Industry
Laboratory Development and Supply Company, Clear Scientific expands their scientific cannabis product line. - March 01, 2018 - Clear Scientific
Ostium Launch a Crowdfunding Campaign with IndieGoGo
Ostium makes it possible to detect illnesses at the stage of early functional disruptions, long before the onset of the first noticeable symptoms. Moreover, Ostium are able to predict, well in advance, many serious ailments, from asthma to tumors. Ostium Lab launch a crowdfunding campaign with IndieGoGo to continue their project, to improve the hardware and software complex, to process state registration and to launch mass production. - February 26, 2018 - Ostium
MCS System NGDS-1 Program Announced as a Finalist in the Medical/Dental Category for the 2018 Edison Awards
The Joint Project Management Office for Medical Countermeasure Systems (JPM-MCS) Next Generation Diagnostic System Increment 1 (NGDS Inc 1) program has been named a finalist in the Medical/Dental category for the 2018 Edison Awards. Established in 1987 and often described as “the Oscars of... - February 26, 2018 - JPM-MCS